Transition to endemic: acceptance of additional COVID-19 vaccine doses among Canadian adults in a national cross-sectional survey.

Reifferscheid, Laura; Lee, Janet Sau Wun; MacDonald, Noni E; Sadarangani, Manish; Assi, Ali; Lemaire-Paquette, Samuel; MacDonald, Shannon E

Reifferscheid, Laura; Lee, Janet Sau Wun; MacDonald, Noni E; Sadarangani, Manish; Assi, Ali; Lemaire-Paquette, Samuel; MacDonald, Shannon E.

Afiliação

Reifferscheid L; Faculty of Nursing, University of Alberta, AB, Edmonton, Canada.
Lee JSW; Faculty of Nursing, University of Alberta, AB, Edmonton, Canada.
MacDonald NE; Department of Pediatrics, Faculty of Medicine, Dalhousie University, NS, Halifax, Canada.
Sadarangani M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada.
Assi A; Department of Pediatrics, University of British Columbia, BC, Vancouver, Canada.
Lemaire-Paquette S; Faculty of Nursing, University of Alberta, AB, Edmonton, Canada.
MacDonald SE; Centre de Recherche du CHUS, QC, Sherbrooke, Canada.

BMC Public Health ; 22(1): 1745, 2022 09 14.

Article em En | MEDLINE | ID: mdl-36104675

Assuntos

COVID-19; Vacinas contra Influenza; Adulto; COVID-19/epidemiologia; COVID-19/prevenção & controle; Vacinas contra COVID-19; Canadá/epidemiologia; Estudos Transversais; Humanos; Aceitação pelo Paciente de Cuidados de Saúde; SARS-CoV-2

Palavras-chave

Annual; Booster dose; COVID-19; Immunization; Seasonal; Third dose; Vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google